Information on bladder cancer

What is bladder cancer?

Bladder cancer is an uncontrolled growth of abnormal cells in the bladder.1 The disease usually begins in the lining of the bladder; however, cancerous cells may spread into the muscular wall of the bladder.1,2

Invasive bladder cancer may spread to:3

Tick
Nearby or distant lymph nodes, other areas of the urinary system
Tick
Organs in the pelvis
Tick
Other organs in the body, such as the liver and lungs

What are common signs of bladder cancer?

Blood in the urine (hematuria) is the most common sign of bladder cancer.4,5

Other symptoms of bladder cancer include:4,5

  • Irritation or pain during urination (dysuria)
  • Urinating more frequently than usual
  • Feeling the constant need to urinate
  • Trouble urinating or having a weak urine stream

If you experience any of these symptoms, contact your doctor as soon as possible. There’s a high likelihood they are symptoms of a less severe condition, but don’t ignore them.4,5

How is bladder cancer diagnosed?

Card Image

If signs and symptoms indicate bladder cancer, exams and tests will be needed to confirm diagnosis such as looking at medical history and performing urine tests to check for blood, infection and other abnormal cells.6

Card Image

If bladder cancer is suspected, a urologist will perform a cystoscopy to look directly into the bladder.6,7

Card Image

If suspicious tissue is found, it will be removed for further testing. The removed tissue is sent to the laboratory to be tested for histological confirmation and final diagnosis, which includes the disease’s stage and grade.6

What is cystoscopy?

A cystoscopy is a procedure used to look directly into the bladder, using a thin, tube-like camera called a cystoscope. This procedure helps urologists examine the bladder so they can find the cause of symptoms and to treat conditions.7,8 

If a urologist finds any abnormal growths or see suspicious areas, they may remove tissue samples (biopsy) and send them to the laboratory.7

A cystoscopy can be done while you are asleep under general anesthesia or while you are awake usually with local anaesthetic.8

References

1. American Cancer Society. What Is Bladder Cancer? 2022. Available at: https://www.cancer.org/cancer/types/bladder-cancer/about/what-is-bladder-cancer.html. Accessed March 2024. 2. Bladder Cancer Advocacy Network. What is Bladder Cancer? Available at: https://bcan.org. Accessed March 2024. 3. Healthline Media LLC. Does Bladder Cancer Spread Quickly? 2022. Available at: https://www.healthline.com/health/bladder-cancer/does-bladder-cancer-spread-quickly#types-that-spread. Accessed March 2024. 4. American Cancer Society. Bladder Cancer Signs and Symptoms. 2019. Available at: https://www.cancer.org/cancer/types/bladder-cancer/detection-diagnosis-staging/signs-and-symptoms.html. Accessed March 2024. 5. Bladder Cancer Advocacy Network. Signs and Symptoms of Bladder Cancer. Available at: https://bcan.org/facing-bladder-cancer/bladder-cancer-signs-symptoms. Accessed March 2024. 6. American Cancer Society. Bladder Cancer Early Detection, Diagnosis, and Staging. 2019. Available at: https://www.cancer.org/cancer/types/bladder-cancer/detection-diagnosis-staging.html. Accessed March 2024. 7. American Cancer Society. Cystoscopy. 2019. Available at: https://www.cancer.org/cancer/diagnosis-staging/tests/endoscopy/cystoscopy.html. Accessed March 2024. 8. Mayo Clinic Healthcare LLP. Cystoscopy. 2022. Available at: https://www.mayoclinic.org/tests-procedures/cystoscopy/about/pac-20393694. Accessed March 2024.

Chevron UpImportant safety information about Cysview® (hexaminolevulinate HCI)
Cysview is an optical imaging agent used to detect non-muscle invasive bladder cancer in patients suspected or known to have lesion(s) on the basis of a prior cystoscopy, or in patients undergoing surveillance cystoscopy for bladder cancer. Cysview is not a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer.
Important Risk & Safety Information for Cysview® (hexaminolevulinate HCl)

Cysview is an optical imaging agent used to detect non-muscle invasive bladder cancer in patients suspected or known to have lesion(s) on the basis of a prior cystoscopy, or in patients undergoing surveillance cystoscopy for bladder cancer. Cysview is not a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer. False-positive fluorescence may occur due to inflammation, trauma from past cystoscopies, scar tissue, previous bladder biopsy, and recent Bacillus Calmette-Guérin (BCG) therapy or intravesical chemotherapy.

Anaphylactoid shock, hypersensitivity reactions, bladder pain, bladder inflammation (cystitis), and abnormal urine tests have been reported after administration of Cysview. The most common adverse reactions seen in clinical trials were bladder spasm, trouble urinating, discomfort when urinating, frequent urination, blood in the urine, and bladder pain.

Cysview should not be used in patients with large amounts of blood in their urine, any known allergy to Cysview or any derivative of aminolevulinic acid, or porphyria, a condition that means you already have high levels of porphyrins in your body. No specific drug interaction studies have been performed.

There are no available data on Cysview use in pediatric patients, pregnant women, or nursing mothers.